Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic-pharmacodynamic relationship

被引:42
|
作者
Roy, JJ [1 ]
Varin, F [1 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
neuromuscular block; agents; pharmacokinetics; potency; protein; binding; solubility; lipid;
D O I
10.1093/bja/aeh181
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background. Among the factors influencing the onset of action of neuromuscular blocking agents (NMBA), the potency (EC50) and the rate of equilibration between blood and the effect compartment (k(e0)) have been highlighted. Although these descriptors are intrinsically influenced by the physicochemical characteristics of the drug, the impact of lipid solubility, molecular weight and protein binding on pharmacokinetic-pharmacodynamic (PK-PD) descriptors has not been established for most NMBA. Methods. The octanol/phosphate buffer distribution coefficients (logD) of various NMBA (vecuronium, rocuronium, mivacurium isomers (cis-cis, cis-trans and trans-trans), doxacurium, cisatracurium, atracurium, succinylcholine) were determined. The free fraction for each drug was measured using an ultrafiltration technique. PK-PD descriptors were obtained from selected clinical studies. Correlations between physicochemical parameters (including molecular weight) and PK-PD descriptors were assessed by linear or multiple linear regression. Results. A wide range of log D (-4.15 for succinylcholine to 0.75 for vecuronium) and free fraction (from 31% for vecuronium to 80% for succinylcholine) is observed for NMBA. Molecular weight combined with either lipid solubility (r(2)=0.70; P=0.001) or free fraction (r(2)=0.84; P<0.001) were highly correlated with potency, while for k(e0) a greater degree of correlation was obtained when both lipid solubility and free fraction (r(2)=0.74; P=0.002) were included. Conclusions. The basic characteristics of NMBAs, namely, molecular weight, lipid solubility and protein binding, are strongly associated with the kinetics of the drug response.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 50 条
  • [1] A pharmacokinetic-pharmacodynamic model for neuromuscular blocking agents to predict train-of-four twitches
    Eleveld, DJ
    De Haes, A
    Proost, JH
    Wierda, JMKH
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2003, 30 (02) : 105 - 118
  • [2] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP
    BAGGOT, JD
    ANNALES DE RECHERCHES VETERINAIRES, 1990, 21 : S29 - S40
  • [3] Impact of chronic inflammation on the pharmacokinetic-pharmacodynamic relationship of naproxen
    Huntjens, Dymphy R. H.
    Spalding, David J. M.
    Danhof, Meindert
    Della Pasqua, Oscar E.
    EUROPEAN JOURNAL OF PAIN, 2010, 14 (03) : 227.e1 - 227.e10
  • [4] STRUCTURE-PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS OF STEROIDAL NEUROMUSCULAR BLOCKING-AGENTS
    WIERDA, JMKH
    PROOST, JH
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1995, 12 : 45 - 54
  • [5] Pharmacokinetic-Pharmacodynamic Model for the Reversal of Neuromuscular Blockade by Sugammadex
    Ploeger, Batt A.
    Smeets, Jean
    Strougo, Ashley
    Drenth, Henk-Jan
    Ruigt, Ge
    Houwing, Natalie
    Danhof, Meindert
    ANESTHESIOLOGY, 2009, 110 (01) : 95 - 105
  • [6] Biomarkers and pharmacokinetic-pharmacodynamic studies of immunosuppressive agents
    Paintaud, G
    Bénéton, M
    Watier, H
    THERAPIE, 2004, 59 (02): : 179 - 183
  • [7] INTRAVENOUS ANESTHETIC AGENTS PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS
    SWERDLOW, BN
    HOLLEY, FO
    CLINICAL PHARMACOKINETICS, 1987, 12 (02) : 79 - 110
  • [8] Role of the pharmacokinetic-pharmacodynamic relationship in drug development
    Bellissant, E
    Courcier-Duplantier, S
    Blin, O
    THERAPIE, 2002, 57 (04): : 347 - 357
  • [9] A Pharmacokinetic–Pharmacodynamic Model for Neuromuscular Blocking Agents to Predict Train-of-Four Twitches
    Douglas J. Eleveld
    Ann De Haes
    Johannes H. Proost
    J. Mark K. H. Wierda
    Journal of Pharmacokinetics and Pharmacodynamics, 2003, 30 : 105 - 118
  • [10] PREDICTION OF THERAPEUTIC DOSES OF BETA-ADRENERGIC-RECEPTOR BLOCKING-AGENTS BASED ON QUANTITATIVE STRUCTURE PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP
    YAMADA, Y
    ITO, K
    NAKAMURA, K
    SAWADA, Y
    IGA, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1993, 16 (12) : 1251 - 1259